Clinical Trials

10 enrolled

Adenocarcinoma, Prostatic Neoplasms

NCT07622225 2026-06-03

SYS6006 in Combination With Enlonstobart Injection Versus Enlonstobart Injection in Participants With Advanced Solid Tumors

264 enrolled

Advanced Solid Tumors

NCT07623356 2026-06-03

A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Non-Small Cell Lung Cancer

265 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07623707 2026-06-03

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

264 enrolled

Solid Tumor

NCT07621159 2026-06-02

A Phase Ib/II Study of HDM2017 in Combination With Standard of Care in Advanced Colorectal Cancer

120 enrolled

Colorectal Cancer Metastatic

NCT07617493 2026-06-01

Evaluation of ICP-B208 in Patients With Advanced Solid Tumors

539 enrolled

Advanced Solid Tumor

NCT07559929 2026-05-29

A Study of DXC006 With Immune Checkpoint Inhibitors or Platinum for Small Cell Lung Cancer.

200 enrolled

Thoracic

Small Cell Lung Carcinoma

NCT07615660 2026-05-29

CVL006-T1003

108 enrolled

Advanced Solid Tumor

NCT07610798 2026-05-28

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patients With Advanced Solid Tumors Harboring KRAS G12D Mutations

GastrointestinalGynecologic

178 enrolled

Biliary Tract Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Rectal Neoplasms, Endometrial Neoplasms

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

282 enrolled

Solid Tumor

NCT07607925 2026-05-27

A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL

49 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Recurrence

NCT07609862 2026-05-27

A Phase Ib/II Study of Rocbrutinib in Combination With Lacutoclax in Patients With B-Cell Malignancies

LymphoidOther hematologic neoplasm

92 enrolled

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07601204 2026-05-22

Treatment of Recurrent/Metastatic Head and Neck Cancer

128 enrolled

Head & Neck

Head and Neck Neoplasms

NCT07602777 2026-05-22

A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)

113 enrolled

Sarcoma

NCT07602842 2026-05-22

A Study of IDP-001 in Advanced or Metastatic Solid Tumors

GastrointestinalHead & Neck

132 enrolled

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Anus Neoplasms, Carcinoma, Squamous Cell, Neoplasm Metastasis

NCT07602855 2026-05-22

A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)

184 enrolled

Solid Tumors

NCT07604285 2026-05-22

NOVA-GBM

36 enrolled

CNS

Glioblastoma

NCT07387926 2026-05-19

Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)

LymphoidOther hematologic neoplasm

50 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07594028 2026-05-18

Phase I/II Study of SCTB41 Plus SCTB39-1with or Without Standard Therapy in Advanced Solid Tumours

126 enrolled

Advanced Malignant Solid Tumor

NCT07594106 2026-05-18

REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma

265 enrolled

Carcinoma, Renal Cell

NCT07564102 2026-05-15

dMD-002 Pilot Study in Patients With Cavernous Nerve Injury Following Radical Prostatectomy

30 enrolled

Prostatic Neoplasms

NCT07590531 2026-05-15

AMT-116 in Combination With Ivosidan in Patients With Lung Cancer

118 enrolled

Thoracic

Advanced Non-small Cell Lung Cancer (NSCLC)

NCT07590934 2026-05-15

PROSPECTOR

152 enrolled

Prostatic Neoplasms

NCT07586943 2026-05-14

SKB118 Injection in Advanced Solid Tumors

332 enrolled

Advanced Solid Tumors

NCT07587879 2026-05-14

mRNA-LNP

60 enrolled

Advanced Solid Tumor

NCT07584057 2026-05-13

An Phase I/IIa Clinical Study to Evaluate the Safety/Tolerability, Pharmacokinetics and Preliminary Efficacy of INB301 Injection in Patients With Cancer Cachexia

146 enrolled

Cancer Cachexia

NCT07581314 2026-05-12

Oral Zn-Telomir Monotherapy in Patients With Advanced or Metastatic Triple-Negative Breast Cancer (TNBC)

76 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07529808 2026-05-08

ChefHat-001

164 enrolled

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07545265 2026-05-08

SKB565 for Injection in Advanced Solid Tumors

180 enrolled

Advanced Solid Tumors

NCT07575191 2026-05-08

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

9 enrolled

Pancreatic Cancer Non-resectable

NCT07570966 2026-05-06

Study of ERW316 as a Single Agent or in Combination With Endocrine Therapy in Patients With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors

217 enrolled

BreastGenitourinary

Breast Neoplasms, Prostatic Neoplasms

NCT07567469 2026-05-05

A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma

120 enrolled

CNS

Ependymoma, Glioma, Neoplasms, Recurrence

NCT07567846 2026-05-05

A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Activity of GDC-1261 in Participants With Advanced or Metastatic Prostate Cancer

260 enrolled

Prostatic Neoplasms

NCT07560124 2026-04-30

A Study of AK138D1 Alone or in Combination With Ivonescimab in Advanced Breast Cancer

286 enrolled

Breast

Breast Neoplasms

NCT07551778 2026-04-27

Allogeneic NK Cell Therapy Combined With Standard Maintenance Treatment in Advanced Solid Tumors

20 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07547553 2026-04-23

A Phase Ib/II Trial to Evaluate the Efficacy and Safety of HH-009 for the Treatment of FGF19-positive Advanced or Unresectable HCC

30 enrolled

Carcinoma, Hepatocellular

NCT03833206 2026-04-20

A Phase I/II Study of PDC-1421 for Treating Depression in Cancer Patients

12 enrolled

Depressive Disorder, Major

NCT05764928 2026-04-20

Evaluate the Safety and Efficacy of BLEX 404 Oral Liquid Combined With Pemetrexed + Cisplatin Therapy

32 enrolled

Nonsquamous Nonsmall Cell Neoplasm of Lung

NCT07537881 2026-04-17

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

326 enrolled

Solid Tumors

NCT07444541 2026-04-16

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

84 enrolled

Pancreatic Neoplasms

NCT07530666 2026-04-15

Study of the Safety and Efficacy of DS010 in Patients With Cancer Cachexia

58 enrolled

Cachexia, Neoplasms

NCT02802423 2026-04-13

Phase I/II, Evaluate the Safety and Efficacy of BLEX 404 With Docetaxel in Patients With Advanced/Metastatic Triple Negative Breast Cancer.

44 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07509684 2026-04-13

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

190 enrolled

Advanced Solid Tumors

NCT07520006 2026-04-13

Study of NX-5948 in Combination With Other Agents in Adults With B-cell Malignancies

LymphoidOther hematologic neoplasm

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell

NCT07514975 2026-04-09

First-In-Human Study of KHN922 for Injection

276 enrolled

Advanced Solid Tumors Cancer

NCT07512583 2026-04-06

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

178 enrolled

Advanced Solid Tumor

NCT07510100 2026-04-03

FUMANBA-04

17 enrolled

Plasma cell

Multiple Myeloma, Recurrence

NCT07468071 2026-04-02

KontRASt-R

40 enrolled

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07508761 2026-04-02

IPG7236 Combined With Toripalimab in Participants With Advanced Solid Tumors

52 enrolled